Dementia — Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia
Citation(s)
Blay SL, Toledo Pisa Peluso E Public stigma: the community's tolerance of Alzheimer disease. Am J Geriatr Psychiatry. 2010 Feb;18(2):163-71. doi: 10.1097/JGP.0b013e3181bea900.
Brannelly T Sustaining citizenship: people with dementia and the phenomenon of social death. Nurs Ethics. 2011 Sep;18(5):662-71. doi: 10.1177/0969733011408049.
Fraboni, M , Saltstone, R., & Hughes, S. (1990). The Fraboni Scale of Ageism (FSA): An Attempt at a More Precise Measure of Ageism. Canadian Journal on Aging / La Revue Canadienne Du Vieillissement, 9(1), 56-66.
Harada, K , Sugisawa, H., Shibata, H., Yamada, Y., & Sugihara, Y. (2004). Measurement and Correlates of Ageism Among Japanese Young Men Living in Urban Areas. The Gerontologist, 44(Special_Issue_I), 1-672.
Kim, K , & Kuroda, K. (2011). Factors related to attitudes toward people with dementia: Development Attitude Toward Dementia Scale and Dementia Knowledge Scale. Bulletin of Social Medicine, 28(1), 43-56 (in Japanese).
Lane AP, Yu FCH Person-centered attitudes mediate the association between dementia knowledge and help-giving intentions in Singapore. Int Psychogeriatr. 2020 Mar;32(3):413-414. doi: 10.1017/S1041610219000796. No abstract available.
Malta S, Doyle C Butler's three constructs of ageism in Australasian Journal on Ageing [corrected]. Australas J Ageing. 2016 Dec;35(4):232-235. doi: 10.1111/ajag.12363. No abstract available. Erratum In: Australas J Ageing. 2017 Mar;36(1):81.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.